Medical Health Cluster

Variantes Covid

Persistent Disparities in COVID-19 Antiviral Dispensing

Communities most at risk of severe COVID-19 outcomes have half the rate of prescriptions compared with less vulnerable communities, according to a CDC report. More than 1 million doses of oral antiviral medications to treat individuals with SARS-CoV-2 have been prescribed since late December 2021 when the US Food and Drug […]

Read More

As Unexplained Hepatitis Spreads, WHO Urges Action

Despite recent progress, more than 350 million people globally live with viral hepatitis and more than 1 million die annually—a greater toll than from HIV and malaria combined. Amid unexplained increases in childhood hepatitis cases in 34 countries, the World Hepatitis Alliance and World Health Organization (WHO) urged renewed efforts to eliminate […]

Read More

Association of Blood Viscosity With Mortality Among Patients Hospitalized With COVID-19

Coronavirus disease-2019 (COVID-19) is characterized by a dysfunctional immune response and abnormal blood rheology that contribute to endothelial dysfunction and thrombotic complications. Whole blood viscosity (WBV) is a clinically validated measure of blood rheology and an established predictor of cardiovascular risk. We hypothesize that increased WBV is associated with mortality […]

Read More

COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies

Pregnant individuals who received a booster dose of the BNT162b2 (Pfizer-BioNTech) COVID-19 mRNA vaccine during their second trimester developed higher antibody levels than those who received the second shot in their primary vaccine series during the same trimester, researchers in Israel recently reported in Obstetrics & Gynecology. Infants in the booster group also […]

Read More

Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association

Evaluation of COVID-19 vaccine booster effectiveness is essential as new variants of SARS-CoV-2 emerge. Data support the effectiveness of booster doses in preventing severe disease and hospitalization; however, the association with reducing incident SARS-CoV-2 infections is not clear.1-3 We compared the incidence of SARS-CoV-2 infection in players and staff of the […]

Read More